Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "vaccine hesitancy"

PolicyEMAMay 11

EMA launches new advisory group on vaccine confidence

The European Medicines Agency (EMA) created a new advisory group to address vaccine hesitancy—when people are unsure about getting vaccines. The group will meet four times a year and includes doctors, patient representatives, and other experts. Their goal is to help the EMA understand why people distrust vaccines and find ways to rebuild confidence in vaccine safety.

WHY IT MATTERSFor patients with rare diseases who may be immunocompromised or at higher risk from vaccine-preventable infections, vaccine confidence directly affects community protection through herd immunity and the safety of vaccines available to them.
Good to know

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases